PACU Discharge Without Motorfunction Assessment After Spinal Anaesthesia

November 24, 2016 updated by: Eske Kvanner Aasvang, Rigshospitalet, Denmark

PACU Discharge Without Motorfunction Assessment After Spinal Anaesthesia for Total Hip or Knee Arthroplasty - a Multicenter Randomized Controlled Trial

The study investigates the safety of discharge from the Post-Anesthesia Care Unit (PACU) without assessment of motorfunction after spinal anesthesia for total hip- or knee replacement. This is an randomized controlled trial between two groups with assessment of normal (Aldrete) PACU discharge criteria with or without assessment of the motorfunction. The study hypothesis is that it is safe to be discharged from the PACU to a ward without assessment of motor function.

The main outcome is length of hospial stay (LOS) in days and re-admission within the first 30 days after surgery .

Secondary outcomes include adverse events up to 24 hours after surgery, and minuttes spent in the PACU after surgery.

Participants will be monitores for adverse events for the first 24 hours after surgery and reported. The total number of minuttes spent in the PACU will be recorded and reported.

Study Overview

Status

Completed

Detailed Description

A novel analysis of the latest database version was performed 06.04.2015, showing that 86.7% of patients have LOS of less than 5 days and no re-admission within the first 30 days after discharge.

The study is designed as a non-inferiority study with a two-sided 5% significance level, 80% power and a non-inferiority level of 5%, resulting in 2 x 725 patients (1500 in total including drop-outs).

A 30-day re-admission period was chosen to detect complications that could be assumed to have occurred as a consequence of the potential earlier PACU discharge The study will also investigate Length of stay, incidence of failed anesthesia, and reason for stay in PACU after THA and TKA 24.11.2016 A substudy based upon the un-published data from the time in PACU will be performed to analyse factors related to adverse events occuring during the PACU stay, and description of specific organdysfunction based upon the recordings from the modifed Aldrete discharge criteria.

Preoperative demographic data are collected from charts and the Lundbeck Centre for Fast-track Hip and Knee Replacement database, (LCDB), intraoperative data from anesthesia charts.

A logistic regression analysis will be performed with the YES/NO outcome of moderate/severe adverse PACU events at any time during PACU stay, and pre- and intr operatie variables.

Study Type

Interventional

Enrollment (Actual)

1511

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Farsø, Denmark, 4640
        • Farsø Sygehus
      • Holstebro, Denmark
        • Holstebro Sygehus
      • Viborg, Denmark
        • Viborg Hospital
    • International
      • Gentofte, International, Denmark, 2900
        • Gentofte Hospital
      • Vejle, International, Denmark, 7100
        • Vejle Sygehus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 18 yr or more
  • primary unilateral total hip or knee arthroplasty
  • spinal anesthesia

Exclusion Criteria:

  • intraoperative conversion to general anesthesia
  • intraoperative bleeding exceeding 750 ml.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: no assessment of motorfunction in PACU
no assessment of motorfunction after spinal anesthesia in PACU
Active Comparator: motorfunction assessment in PACU
Assesment of motorfunction after spinal anesthesia
assessment of motorfunction in PACU after spinal anesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lenght of stay (in days) or 30 day readmissions
Time Frame: 30 days
The main outcome is a compund measure of the duration of hospitalization after operation )measured in days, and named Length of Stay LOS) adn/or re-admission within the first 30 days after discharge.
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events
Time Frame: 24 hours postooperatively
Any event that results in a physicians assessment of the patient, not including regular rounds during the first 24 hours after surgery.
24 hours postooperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to discharge from PACU
Time Frame: 12 hours
Time from arrival to discharge i PACU measured in minuttes
12 hours
Discharge readiness before leaving the operating theater
Time Frame: 1 hour
How many patients fulfilled the PACU discahrge criteria at the time they were leaving the operating theater
1 hour
Failed spinal anesthesia.
Time Frame: 6 hours.
Incidence and related factors to failed spinal anesthesia (ie. conversion to generel anesthesia)
6 hours.
Prediction of PACU complications
Time Frame: 0-7 hours
Factors related to, and incidence of, moderate/severe complications i PACU
0-7 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Henrik Kehlet, Professor, Rigshospitalet, Denmark
  • Principal Investigator: Eske K Aasvang, M.D., DMSci, Rigshospitalet, Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

April 28, 2014

First Submitted That Met QC Criteria

May 8, 2014

First Posted (Estimate)

May 9, 2014

Study Record Updates

Last Update Posted (Estimate)

November 28, 2016

Last Update Submitted That Met QC Criteria

November 24, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis Susceptibility 3

Clinical Trials on assessment of motorfunction in PACU

Subscribe